- Home
- LEGN vs MAIN Comparison
LEGN vs MAIN Comparison
Compare LEGN & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- MAIN
- Stock Information
- Founded
- LEGN 2014
- MAIN 2007
- Country
- LEGN United States
- MAIN United States
- Employees
- LEGN N/A
- MAIN N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- MAIN Finance/Investors Services
- Sector
- LEGN Health Care
- MAIN Finance
- Exchange
- LEGN Nasdaq
- MAIN Nasdaq
- Market Cap
- LEGN 6.3B
- MAIN 5.8B
- IPO Year
- LEGN 2020
- MAIN 2007
- Fundamental
- Price
- LEGN $31.46
- MAIN $61.45
- Analyst Decision
- LEGN Strong Buy
- MAIN Hold
- Analyst Count
- LEGN 12
- MAIN 5
- Target Price
- LEGN $73.36
- MAIN $61.20
- AVG Volume (30 Days)
- LEGN 1.2M
- MAIN 601.8K
- Earning Date
- LEGN 11-11-2025
- MAIN 11-06-2025
- Dividend Yield
- LEGN N/A
- MAIN 6.90%
- EPS Growth
- LEGN N/A
- MAIN 13.61
- EPS
- LEGN N/A
- MAIN 6.07
- Revenue
- LEGN $796,838,000.00
- MAIN $558,286,000.00
- Revenue This Year
- LEGN $69.31
- MAIN $6.26
- Revenue Next Year
- LEGN $52.73
- MAIN $3.47
- P/E Ratio
- LEGN N/A
- MAIN $10.18
- Revenue Growth
- LEGN 74.75
- MAIN 8.13
- 52 Week Low
- LEGN $27.34
- MAIN $47.00
- 52 Week High
- LEGN $51.77
- MAIN $67.77
- Technical
- Relative Strength Index (RSI)
- LEGN 31.45
- MAIN 34.73
- Support Level
- LEGN $32.02
- MAIN $62.36
- Resistance Level
- LEGN $32.62
- MAIN $64.21
- Average True Range (ATR)
- LEGN 1.02
- MAIN 1.37
- MACD
- LEGN -0.09
- MAIN -0.30
- Stochastic Oscillator
- LEGN 6.87
- MAIN 6.16
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About MAIN Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.